A friend within the heart: Natriuretic peptide receptor signaling

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1275-1277

  Molkentin, Jeffery D ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; G PROTEIN COUPLED RECEPTOR; GUANYLATE CYCLASE; PHOSPHATASE; PROTEIN TYROSINE KINASE;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL; RECEPTOR BINDING; SECOND MESSENGER; SIGNAL TRANSDUCTION; VALVULAR HEART DISEASE;

EID: 0037651250     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18389     Document Type: Note

References (22)

1. Lorell, B.H., and Carabello, B.A. 2000. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 102:470-479.
2. Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., and Castelli, W.P. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322:1561-1566.
3. Molkentin, J.D., and Dorn, G.W., II. 2001. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63:391-426.
4. Holtwick, R., et al. 2003. Pressure-independent cardiac hypertrophy in mice with cardiomyocyterestricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J. Clin. Invest. 111:1399-1407. doi:10.1172/JCI200317061.
5. Misono, K.S. 2002. Natriuretic peptide receptor: structure and signaling. Mol. Cell Biochem. 230:49-60.
6. Tremblay, J., Desjardins, R., Hum, D., Gutkowska, J., and Hamet, P. 2002. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell Biochem. 230:31-47.
7. Silberbach, M., and Roberts, C.T., Jr. 2001. Natriuretic peptide signaling: molecular and cellular pathways to growth regulation. Cell Signal. 13:221-231.
8. Lainchbury, J.G., et al. 1997. Cardiac natriuretic peptides as predictors of mortality. J. Intern. Med. 241:257-259.
9. Klinger, J.R., et al. 1993. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J. Appl. Physiol. 75:198-205.
10. Kishimoto, I., Rossi, K., and Garbers, D.L. 2001. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 98:2703-2706.
11. Oliver, P.M., et al. 1997. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U. S. A. 94:14730-14735.
12. Lopez, M.J., et al. 1995. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 378:65-68.
13. Masciotra, S., Picard, S., and Deschepper, C.F. 1999. Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ. Res. 84:1453-1458.
14. Knowles, J.W., et al. 2001. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J. Clin. Invest. 107:975-984.
15. Kuhn, M., et al. 2002. Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart. 87:368-374.
16. Ellmers, LJ., et al. 2002. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 283:H707-H714.
17. Calderone, A., Thaik, C.M., Takahashi, N., Chang, D.L., and Colucci, W.S. 1998. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101:812-818.
18. Silberbach, M., et al. 1999. Extracellular signalregulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274:24858-24864.
19. Horio, T., et al. 2000. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension. 35:19-24.
20. Fiedler, B., et al. 2002. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc. Natl. Acad. Sci. U. S. A. 99:11363-11368.
21. John, S. W., et al. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science. 267:679-681.
22. Keating, G.M., and Goa, K.L. 2003. Nesiritide: a review of its use in acute decompensated heart failure. Drugs. 63:47-70.